1. Home
  2. GOSS vs TRTX Comparison

GOSS vs TRTX Comparison

Compare GOSS & TRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.44

Market Cap

101.2M

Sector

Health Care

ML Signal

HOLD

Logo TPG RE Finance Trust Inc.

TRTX

TPG RE Finance Trust Inc.

HOLD

Current Price

$7.99

Market Cap

651.1M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOSS
TRTX
Founded
2015
2014
Country
United States
United States
Employees
145
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
101.2M
651.1M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
GOSS
TRTX
Price
$0.44
$7.99
Analyst Decision
Buy
Buy
Analyst Count
9
4
Target Price
$4.91
$10.17
AVG Volume (30 Days)
26.7M
747.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
11.85%
EPS Growth
78.81
N/A
EPS
N/A
N/A
Revenue
$114,701,000.00
N/A
Revenue This Year
N/A
$8.81
Revenue Next Year
N/A
$16.96
P/E Ratio
N/A
$14.82
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$6.47
52 Week High
$3.87
$9.85

Technical Indicators

Market Signals
Indicator
GOSS
TRTX
Relative Strength Index (RSI) 22.21 30.11
Support Level $0.33 $7.63
Resistance Level $0.60 $8.09
Average True Range (ATR) 0.06 0.20
MACD 0.04 -0.04
Stochastic Oscillator 45.47 3.03

Price Performance

Historical Comparison
GOSS
TRTX

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About TRTX TPG RE Finance Trust Inc.

TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating-rate first mortgage loans that are secured by high-quality commercial real estate properties undergoing some form of transition and value creation.

Share on Social Networks: